DSM-Firmenich AG (XSWX:DSFIR) ROCE %: -0.45% (As of Dec. 2025)


XSWX:DSFIR DSM-Firmenich AG XSWX:DSFIR
32 GF Score
Price CHF74.82
GF Value CHF70.90
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is DSM-Firmenich AG ROCE %?

DSM-Firmenich AG XSWX:DSFIR +5.62% 32 ROCE % is -0.45% as of Dec. 2025. GuruFocus rates XSWX:DSFIR with a GF Score™ of 32/100 and a GF Value™ of CHF70.90 (Fairly Valued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. DSM-Firmenich AG's annualized ROCE % for the quarter that ended in Dec. 2025 was -0.45%.

DSM-Firmenich AG  (XSWX:DSFIR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

DSM-Firmenich AG ROCE % Related Terms

DSM-Firmenich AG ROCE % Historical Data

* Premium members only.

The historical data trend for DSM-Firmenich AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DSM-Firmenich AG ROCE % Chart

DSM-Firmenich AG Annual Data
Trend Dec21 Dec23 Dec24 Dec25
ROCE %
0.00 -1.61 1.98 2.74

DSM-Firmenich AG Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial -0.71 1.09 2.95 5.41 -0.45
XSWX:DSFIR
32GF Score
DSM-Firmenich AG XSWX:DSFIR
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DSM-Firmenich AG ROCE % Calculation

DSM-Firmenich AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=678.391/( ( (31506.623 - 4070.551) + (27382.94 - 5219.042) )/ 2 )
=678.391/( (27436.072+22163.898)/ 2 )
=678.391/24799.985
=2.74 %

DSM-Firmenich AG's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-110.11/( ( (30314.445 - 3205.903) + (27382.94 - 5219.042) )/ 2 )
=-110.11/( ( 27108.542 + 22163.898 )/ 2 )
=-110.11/24636.22
=-0.45 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -0.45% mean?
DSM-Firmenich AG (XSWX:DSFIR) has a ROCE % of -0.45% as of Dec. 2025.
Is DSM-Firmenich AG's ROCE % too high?
DSM-Firmenich AG's current ROCE % is -0.45%. Overall, DSM-Firmenich AG has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's ROCE % compare to LIN and SHW?
DSM-Firmenich AG's ROCE % of -0.45% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Chemicals company?
The median ROCE % among Chemicals companies is 6.45, based on 1,594 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DSM-Firmenich AG's current ROCE % is -0.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Fairly Valued. The stock's GF Value™ is CHF70.90, compared to a current price of CHF74.82 — trading 5.5% above its estimated fair value. The current ROCE % is -0.45%. DSM-Firmenich AG's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current ROCE % is -0.45% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of CHF74.82 is trading 5.5% above its estimated GF Value™ of CHF70.90. GuruFocus considers DSM-Firmenich AG to be Fairly Valued.

Key valuation signals for XSWX:DSFIR:

  • ROCE %: -0.45%
  • GF Value™: CHF70.90 vs. price of CHF74.82 (5.5% above fair value)
  • GF Score™: 32/100 with 5 warning signs

No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
32GF Score

Get the complete analysis for XSWX:DSFIR

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF74.82
Price
CHF70.90
GF Value